Contextualizing biological heterogeneity in brain structural normativity assessments across the aging continuum with the nearest neighbor normativity framework
Abstract Background: Despite established consensus about the individuality of brain physiology and structural changes, current neuroimaging biomarker paradigms heavily rely on population averages. Here, we define normativity not as a single reference point but as a landscape of permissible configurations arising from diverse physiological manifestations. Methods: We introduce the Nearest Neighbor Normativity (N 3 ) framework, designed to parse the natural heterogeneity in brain structural measurements into a diversity-aware biomarker of brain structural decline. Through repeated comparisons within different demographic subgroups, N 3 contextualizes an individual’s measurements from several viewpoints along the aging continuum. Relying on local density estimation, it accommodates multiple, shared normative configurations within and across age groups. We use T1-weighted MRI data from 29,883 individuals for training and 7,013 individuals for validation, and benchmark our framework against Brain Age models and Normative Modeling. We evaluate each biomarker’s ability to detect neurodegenerative diseases, using them as representative models of atypical brain structural decline. Results: In group-level analyses, the N 3 biomarker shows the largest effect sizes in the detection of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia. Similarly, the N 3 biomarker achieves the highest predictive performance in the classification of neurodegenerative diseases on a single subject level. Notably, the N 3 estimates remain stable across age and robust to compositional changes in the reference sample. Finally, correlation analyses indicate that it captures distinct and complementary aspects of brain structural variation compared to existing approaches. Conclusions: Our findings underscore that rethinking normativity assessments to explicitly accommodate natural inter-individual variability can advance our collective efforts toward truly personalized patient care.
Authors
- James Howard Cole (ORCID: https://orcid.org/0000-0003-1908-5588)
- L. Fisch (ORCID: https://orcid.org/0000-0001-6424-7676)
- Janik Goltermann (ORCID: https://orcid.org/0000-0003-3087-1002)
- Elisabeth Johanna Leehr (ORCID: https://orcid.org/0000-0002-9264-5003)
- Xiaoyi Jiang (ORCID: https://orcid.org/0000-0001-7678-9528)
- Dominik Grotegerd (ORCID: https://orcid.org/0000-0001-8718-0128)
- Susanne L. Meinert (ORCID: https://orcid.org/0000-0003-2177-7161)
- Johannes Haubold (ORCID: https://orcid.org/0000-0003-4843-5911)
- Ramona Leenings (ORCID: https://orcid.org/0000-0002-9137-7510)
- Nils Ralf Winter (ORCID: https://orcid.org/0000-0002-6241-1492)
- Maike Frederike Richter (ORCID: https://orcid.org/0000-0003-4078-3954)
- Vincent Holstein (ORCID: https://orcid.org/0000-0002-5722-4254)
- Jan Ernsting (ORCID: https://orcid.org/0000-0003-4649-2111)
- Tim Hahn (ORCID: https://orcid.org/0000-0001-6541-3795)
- Tobias Pischon (ORCID: https://orcid.org/0000-0003-1568-767X)
- Nils Opel (ORCID: https://orcid.org/0000-0003-4749-3298)
- Udo Dannlowski (ORCID: https://orcid.org/0000-0002-0623-3759)
- Klaus Berger
- Carlotta Barkhau (ORCID: https://orcid.org/0000-0002-7546-9183)
- Thoralf Niendorf (ORCID: https://orcid.org/0000-0001-7584-6527)
- Lilian Krist (ORCID: https://orcid.org/0000-0002-6089-5163)
- Annette Peters (ORCID: https://orcid.org/0000-0001-6645-0985)
- Stefan N. Willich (ORCID: https://orcid.org/0009-0006-1270-2597)
- Maximilian Konowski (ORCID: https://orcid.org/0009-0009-2790-9330)
- Henry Völzke
- Hans-Ulrich Kauczor
- Jennifer Spanagel (ORCID: https://orcid.org/0009-0006-5391-4668)
Institutions
- Broad Institute (US)
- Boston University (US)
- University of Southern California (US)
- Johannes Kepler University of Linz (AT)
- Mayo Clinic (US)
- University of Wisconsin–Madison (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- Fordham University (US)
- University of California, San Francisco (US)
- Bielefeld University (DE)
- University of Washington (US)
- Washington University in St. Louis (US)
- Max Delbrück Center (DE)
- University of Münster (DE)
- Universitätsmedizin Greifswald (DE)
- McLean Hospital (US)
- University Hospital Heidelberg (DE)
- Helmholtz Zentrum München (DE)
- Kepler Universitätsklinikum (AT)
- Essen University Hospital (DE)
- German Centre for Cardiovascular Research (DE)
- Jena University Hospital (DE)
- Eisai (United States) (US)
- German Center for Diabetes Research (DE)
- Northern California Institute for Research and Education (US)
- Indiana University Indianapolis (US)
- Stanley Center for Psychiatric Research (US)
- Deutsches Zentrum für Psychische Gesundheit (DE)
- UCL Queen Square Institute of Neurology (GB)
- Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (DE)
- University College London (GB)
- FH Münster University of Applied Sciences (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Pennsylvania (US)
- Ludwig-Maximilians-Universität München (DE)
- University of California, Davis (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Communications Medicine
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s43856-026-01903-0
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 3.30
Funders
- U.S. Department of Defense
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Massachusetts General Hospital
- Biogen
- University of Southern California
- F. Hoffmann-La Roche
- Meso Scale Diagnostics
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- University of Washington
- Novartis Pharmaceuticals Corporation
- Northern California Institute for Research and Education
- Commonwealth Scientific and Industrial Research Organisation
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Eisai
- Servier
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- University of California, San Francisco
- Canadian Institutes of Health Research
- Leibniz-Gemeinschaft
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering